NASH/NAFLD/FIBROSIS

NASH (non-alcoholic steatohepatitis), NAFLD (non-alcoholic fatty liver disease), and fibrosis continue to affect patients with increasing prevalence and adversity.

Cisbio offers a wide product range for the investigation of the molecular mechanisms involved in the development and progression of NASH, NAFLD and Fibrosis.

Download Poster
Download Fox01 application note
Watch Webinar Trends in Fibrosis Research and Drug Discovery: Nonalcoholic Steatohepatitis (NASH)